Haloperidol Oral Solution Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 2 mg/mL
Reference Brands: Haldol®(US)
Category:
Antipsychotropic Drugs
Haloperidol oral solution is FDA-approved in the United States for the treatment of schizophrenia, Tourette’s syndrome, and severe behavioral problems. In the EU, it is authorized in several countries under national procedures, often used in psychiatric and geriatric care. Regulatory requirements include GMP compliance, accurate dosing validation, stability data, and safety documentation covering extrapyramidal and cardiac risks (e.g., QT prolongation). U.S. labeling must meet FDA standards with appropriate boxed warnings. EU applications require pharmacovigilance planning and risk minimization strategies. To explore dossier-ready Haloperidol oral solutions and other forms, visit Pharmatradz.com — your reliable B2B pharma sourcing partner.
Haloperidol Oral Solution is available in Oral Solution
and strengths such as 2 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Haloperidol Oral Solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Haloperidol Oral Solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Haloperidol, commercially known as Haldol®, is a typical antipsychotic used worldwide for treating schizophrenia, acute psychosis, and Tourette's syndrome. It is also effective in managing severe behavioral disorders and agitation. Available in tablet, oral solution, and injectable forms, Haloperidol comes in strengths ranging from 0.5 mg to 100 mg/mL, including long-acting decanoate injections. Haloperidol is widely approved and used in both the US and EU, making it a staple product for hospitals, clinics, and psychiatric care. Pharmaceutical buyers can explore API suppliers, contract manufacturers, and formulators for Haloperidol at Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing